Are Plasma Citrulline and Glutamine Biomarkers of Intestinal Absorptive Function in Patients With Short Bowel Syndrome?

Sensitive biomarkers for intestinal absorptive function would be clinically useful in short bowel syndrome (SBS). Citrulline (Cit) is a product of the metabolism of glutamine (Gln) and derived amino acids by enterocytes. Cit is produced almost exclusively by the gut, which is also a major site of Gl...

Full description

Saved in:
Bibliographic Details
Published inJPEN. Journal of parenteral and enteral nutrition Vol. 31; no. 1; pp. 1 - 7
Main Authors Luo, Menghua, Fernández-Estívariz, Concepción, Manatunga, Amita K., Bazargan, Niloofar, Gu, Li H., Jones, Dean P., Klapproth, Jan-Michael, Sitaraman, Shanthi V., Leader, Lorraine M., Galloway, John R., Ziegler, Thomas R.
Format Journal Article
LanguageEnglish
Published Silver Spring, MD SAGE Publications 01.01.2007
ASPEN
American Society for Parenteral and Enteral Nutrition
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Sensitive biomarkers for intestinal absorptive function would be clinically useful in short bowel syndrome (SBS). Citrulline (Cit) is a product of the metabolism of glutamine (Gln) and derived amino acids by enterocytes. Cit is produced almost exclusively by the gut, which is also a major site of Gln metabolism. The goals of this study were to examine whether plasma Cit and Gln concentrations are biomarkers of residual small intestinal length and nutrient absorptive functions in adult SBS patients followed prospectively. We studied 24 stable adults with severe SBS receiving chronic parenteral nutrition (PN) in a double-blind, randomized trial of individualized dietary modification± recombinant human growth hormone (GH). During a baseline week, intestinal absorption studies (% absorption of fluid, kcal, nitrogen, fat, carbohydrate, sodium, phosphorus, and magnesium) were performed and concomitant plasma Cit and Gln concentrations determined. Individualized dietary modification and treatment with subcutaneous injection of placebo (n = 9) or GH (0.1 mg/kg daily × 21 days, then 3 times/week; n = 15) were then begun. PN weaning was initiated after week 4 and continued as tolerated for 24 weeks. Repeat plasma amino acid determination and nutrient absorption studies were performed at weeks 4 and 12. Residual small bowel length at baseline was positively correlated with baseline plasma Cit (r = 0.467; p = .028). However, no significant correlations between absolute Cit or Gln concentrations and the percent absorption of nutrient substrates at any time point were observed. Similarly, no correlation between the change in Cit or GLN concentration and the change in % nutrient absorption was observed (baseline vs weeks 4 and 12, respectively). By weeks 12 and 24, 7 and 13 subjects were weaned completely from PN, respectively. However, baseline plasma Cit or Gln did not predict PN weaning at these time points. We concluded that plasma Cit (but not Gln) concentrations appeared to be an indicator of small intestinal length in adult SBS. However, neither plasma Cit nor Gln was a biomarker for intestinal absorptive function in this cohort of patients with SBS. In 24 subjects with severe short bowel syndrome, plasma citrulline concentration was positively correlated with the length of residual small intestine. However, serial measures of plasma citrulline or glutamine concentrations were not significantly correlated with concomitant intestinal macronutrient or micronutrient absorption and did not predict parenteral nutrition dependency during a 24-week follow-up.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0148-6071
1941-2444
DOI:10.1177/014860710703100101